Amarillo Biosciences, Inc.   Report issue

For profit Phase 2
Founded: Amarillo TX United States (1984)
Status: No NME R&D (1984)

Organization Overview

First Clinical Trial
2000
NCT01442779
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now